Methylmalonic acidaemia is a rare inherited disorder that affects how the body processes certain proteins and fats, leading to a dangerous buildup of toxic substances that can cause serious health problems from the first days of life onwards.
What is Methylmalonic Acidaemia?
Methylmalonic acidaemia, also known as methylmalonic aciduria or simply MMA, is a group of rare genetic conditions that prevent the body from properly breaking down certain building blocks of proteins and fats. When you eat protein-rich foods, your body works hard to break them down into smaller pieces that can be used for energy or growth. In people with MMA, one crucial step in this process doesn’t work correctly, causing a substance called methylmalonic acid to build up in the blood, urine, and other body tissues, including the brain.[1]
The disorder happens because of problems with an enzyme called methylmalonyl-CoA mutase, which normally helps convert certain breakdown products from proteins and fats into a form the body can use. Without this enzyme working properly, or without enough of the vitamin B12 that helps it function, harmful substances accumulate and can damage organs throughout the body. The liver is where most of this processing happens, which is why MMA is sometimes described as a liver disorder, though it affects many other parts of the body too.[2]
The effects of methylmalonic acidaemia can range from mild to life-threatening, depending on how severe the enzyme deficiency is. Some children with certain types of MMA respond well to vitamin B12 supplements, while others have forms of the disease that don’t improve with this treatment. The condition typically appears within the first few days or months of life, though in some cases symptoms may not develop until later in childhood or even adolescence.[1]
How Common is Methylmalonic Acidaemia?
Methylmalonic acidaemia is considered a rare disease, though the exact number of people affected varies significantly around the world. In general, the condition is estimated to occur in approximately one in every 25,000 to 48,000 births, though some experts believe the true number may be higher because many cases might go unrecognized, especially when babies die shortly after birth before a diagnosis can be made.[1][3]
The frequency of MMA differs considerably depending on geographic location and ethnic background. A recent analysis found that rates vary from about 0.79 per 100,000 newborns in Asia-Pacific countries to 6.04 per 100,000 in the Middle East and North Africa region. In Europe, estimates suggest around one case for every 50,000 births, while some populations may have higher rates due to specific genetic factors or patterns of inheritance within communities.[11][12]
The disease affects boys and girls equally, as it follows what is called an autosomal recessive pattern of inheritance. This means that both parents must carry a copy of the faulty gene for their child to develop the condition. With the introduction of expanded newborn screening programs in many countries, more cases are being identified early, before symptoms appear, which allows treatment to begin sooner.[8]
What Causes Methylmalonic Acidaemia?
Methylmalonic acidaemia is caused by changes, called mutations, in specific genes that provide instructions for making proteins the body needs. These mutations are inherited from parents, meaning they are passed down through families. For a child to develop MMA, they must inherit a faulty copy of the gene from both their mother and their father. Parents who each carry one copy of the mutated gene are called carriers and typically don’t show any symptoms themselves.[2][8]
People with methylmalonic acidaemia can be divided into different groups based on what is causing their enzyme to malfunction. The most common type is called isolated MMA, where only methylmalonic acid levels are elevated. This form is caused by mutations in genes called MUT, MMAA, or MMAB. About half of all people with isolated MMA have mutations in the MUT gene, which provides instructions for making the methylmalonyl-CoA mutase enzyme itself. When this gene is faulty, the enzyme either doesn’t form properly or isn’t made in sufficient amounts.[1][3]
Another group of people with MMA have combined defects where both methylmalonic acid and another substance called homocysteine build up in the body. These cases are caused by problems in how the body processes vitamin B12, also called cobalamin. The genes responsible include cblA, cblB, cblC, cblD, cblE, cblF, cblG, cblH, and cblJ. Vitamin B12 acts as a helper molecule, or cofactor, that allows the methylmalonyl-CoA mutase enzyme to do its job. When the body can’t properly convert vitamin B12 into the active form needed by the enzyme, methylmalonic acid accumulates even though the enzyme itself might be normal.[3][13]
The specific gene mutations identified in the MUT gene, which has been mapped to a location on chromosome 6, can take many forms. There can be deletions where pieces of the gene are missing, insertions where extra genetic material is added, or missense mutations where a single building block of the gene is changed. Some mutations result in complete absence of enzyme activity (called mut0 type), while others lead to reduced but still present enzyme activity (called mut- type). The severity of symptoms often depends on which type of mutation a person has.[3][13]
It’s worth noting that while MMA is a genetic disorder, not all cases of methylmalonic acid buildup are due to inherited mutations. Vitamin B12 deficiency due to dietary lack or absorption problems can also cause methylmalonic acid to accumulate in the body, but these cases are not considered true methylmalonic acidaemia since they are not caused by genetic defects and can usually be corrected by addressing the underlying vitamin deficiency.[1]
Risk Factors for Methylmalonic Acidaemia
The primary risk factor for developing methylmalonic acidaemia is having parents who both carry a mutation in one of the genes associated with the condition. When both parents are carriers, there is a 25 percent chance with each pregnancy that their child will inherit both faulty genes and develop MMA. There is a 50 percent chance that the child will be a carrier like the parents, and a 25 percent chance that the child will inherit two normal copies of the gene.[2]
Certain populations and ethnic groups may have higher rates of MMA due to what is called a founder effect, where specific genetic mutations become more common in isolated or closely related communities. Families with a history of unexplained infant deaths or developmental problems in previous generations may be at higher risk, as these could represent undiagnosed cases of metabolic disorders like MMA. Consanguinity, or marriage between close relatives, also increases the risk because it raises the likelihood that both parents will carry the same recessive genetic mutation.[12]
Geographic location plays a role in risk as well. Studies have shown that rates of methylmalonic acidaemia are notably higher in certain regions, particularly the Middle East and North Africa, compared to other parts of the world. This suggests that specific populations may carry higher frequencies of the genetic mutations that cause MMA. However, because the condition is so rare overall, most children with MMA are born to parents who had no known family history of the disease and were unaware they were carriers.[11]
Symptoms and Warning Signs
The symptoms of methylmalonic acidaemia typically appear in early infancy, often within the first few days or weeks after birth, though some children don’t show signs until later in the first year of life. The initial presentation is often dramatic and can be life-threatening. Babies may seem perfectly normal at birth but then rapidly deteriorate as they begin feeding and taking in more protein. The condition causes what doctors call a metabolic crisis or decompensation event, which occurs when toxic substances build up to dangerous levels in the blood.[2][8]
During these episodes of severe illness, babies typically show signs of extreme tiredness, known as lethargy. They may be difficult to wake up and show little interest in feeding. Poor feeding and loss of appetite are common early symptoms, and parents often notice that their baby refuses the breast or bottle and may seem weak or floppy. This weakness is due to decreased muscle tone, called hypotonia, which causes the baby to feel like a rag doll when picked up.[1][2]
Vomiting is another frequent symptom, often severe and persistent. The buildup of acids in the blood causes what is called metabolic acidosis, making the blood too acidic, which triggers vomiting and contributes to dehydration. Babies with MMA may breathe rapidly as their bodies try to compensate for the acid-base imbalance. In severe cases, high levels of ammonia in the blood, called hyperammonemia, can develop, which can affect brain function and lead to altered mental states, seizures, or even coma if not treated promptly.[6][10]
Seizures can occur in some children with MMA and represent a serious complication. The disease can also cause stroke-like episodes, particularly affecting an area of the brain called the globus pallidus. These neurological events can lead to lasting damage and contribute to developmental delays and intellectual disability that some children with MMA experience. Without rapid treatment, these acute episodes can lead to coma and death in some cases.[2][3]
Beyond the acute symptoms, children with methylmalonic acidaemia often experience chronic health problems over time. Growth problems are common, with many children falling behind expected height and weight measurements, a condition known as failure to thrive. Developmental delays may become apparent as children grow, ranging from mild delays in reaching milestones like walking and talking to more significant intellectual and motor disabilities. Vision problems can develop in some children, and an enlarged liver may be detected during physical examination.[2][8]
Long-term complications that can develop as children with MMA age include chronic kidney disease, which almost exclusively affects those with methylmalonic acidaemia rather than related conditions. The kidneys gradually lose their ability to filter waste properly, and kidney failure can eventually occur. Some people with MMA also develop heart problems, including a condition called cardiomyopathy where the heart muscle becomes weakened. Bone marrow suppression can occur during prolonged metabolic decompensation, resulting in a low white blood cell count called neutropenia, which increases susceptibility to infections.[2][6][12]
It’s important to note that the severity and combination of symptoms can vary considerably from one person to another, even among those with the same type of MMA. Some children have a more severe form with frequent episodes of metabolic crisis requiring hospitalization, while others have milder forms with fewer acute episodes but still face long-term health challenges. Those with vitamin B12-responsive forms of MMA may have milder symptoms that improve with vitamin supplementation.[1]
Prevention Strategies
Because methylmalonic acidaemia is an inherited genetic disorder, it cannot be prevented in the traditional sense through lifestyle changes or environmental modifications. However, there are several important strategies that can help prevent the severe complications of the disease and improve outcomes for affected individuals. The most significant preventive measure is early detection through newborn screening programs, which test babies shortly after birth before symptoms appear.[8][18]
Many countries and regions have implemented expanded newborn screening that includes testing for methylmalonic acidaemia. This involves taking a small blood sample from the baby’s heel within the first few days of life and analyzing it for elevated levels of certain substances, particularly a compound called C3 acylcarnitine (also known as propionyl carnitine). When levels are abnormal, additional testing can confirm whether the baby has MMA. Early identification allows treatment to begin before the first metabolic crisis occurs, potentially preventing brain damage and other serious complications.[5][18]
For families known to be at risk because of a previous child with MMA or carrier testing results, genetic counseling can provide valuable information about the chances of having an affected child. In some cases, prenatal testing through procedures like amniocentesis or chorionic villus sampling can detect whether a developing baby has inherited the genetic mutations that cause MMA. This information allows families to prepare for the specialized care their child will need and ensures that medical teams are ready to begin treatment immediately after birth.[8]
Once a diagnosis of MMA is made, preventing metabolic crises becomes a critical focus. People with MMA must follow a carefully controlled low-protein diet throughout their lives to reduce the intake of amino acids that the body cannot properly process. The specific amounts of protein allowed vary depending on the severity of the condition and the individual’s age and growth needs. A specialized medical team, including metabolic specialists and trained dietitians, works with families to develop meal plans that provide adequate nutrition while avoiding dangerous buildup of toxic substances.[2][8]
Avoiding illness and stress on the body is another important preventive strategy for people with MMA. Common infections like colds, flu, stomach bugs, or any other illness that causes fever, vomiting, or poor eating can trigger a metabolic crisis. During times of illness, the body breaks down its own proteins for energy, which releases the same amino acids that people with MMA cannot process. Therefore, families are advised to avoid exposure to sick individuals when possible and to seek medical attention promptly at the first signs of illness. Having an emergency protocol in place is essential so that treatment with intravenous fluids and glucose can begin quickly if needed.[6][8]
Regular medical monitoring is crucial for preventing complications. This includes frequent blood and urine tests to check levels of methylmalonic acid and other substances, assessments of kidney function, growth measurements, developmental evaluations, and regular eye exams. Staying up to date with vaccinations helps prevent infections that could trigger metabolic problems. Some people with MMA take daily supplements of carnitine and vitamin B12, which can help manage the condition in certain cases, though not all types of MMA respond to these supplements.[8][17]
How the Disease Affects the Body
To understand how methylmalonic acidaemia affects the body, it helps to know what happens during normal metabolism. When we eat foods containing protein, the body breaks these proteins down into their building blocks called amino acids. Four specific amino acids—isoleucine, valine, methionine, and threonine—go through a series of chemical reactions that eventually lead to the production of a substance called propionyl-CoA. This substance is then converted to methylmalonyl-CoA and finally to succinyl-CoA, which enters an important energy-producing cycle in cells called the tricarboxylic acid cycle. The breakdown of odd-chain fatty acids and cholesterol also feeds into this same pathway.[3][6]
The conversion of methylmalonyl-CoA to succinyl-CoA requires the enzyme methylmalonyl-CoA mutase to work properly, and this enzyme needs vitamin B12 in the form of adenosylcobalamin as a helper molecule. In people with methylmalonic acidaemia, either the enzyme itself doesn’t work correctly, or there is a problem with producing the active form of vitamin B12 that the enzyme needs. Without this crucial step functioning, methylmalonyl-CoA and its precursor propionyl-CoA accumulate and are converted into methylmalonic acid and other toxic substances like propionic acid and methylcitric acid.[3][10][13]
The accumulation of these toxic metabolites causes multiple problems throughout the body. First, they produce a dangerous condition called metabolic acidosis, where the blood becomes too acidic. The body tries to compensate by breathing faster to blow off carbon dioxide, which can lead to a condition called hypocapnia (low carbon dioxide in the blood). The combination of acidosis and hypocapnia can cause blood vessels to constrict, reducing blood flow to vital organs including the brain. This reduced blood flow may explain the stroke-like episodes that occur in some people with MMA, particularly in an area of the brain called the basal ganglia.[3][6]
The toxic metabolites may also directly damage nerve cells and the supporting cells in the brain called glial cells. Studies using magnetic resonance spectroscopy have shown that a substance called lactate builds up in damaged areas of the brain in people with MMA, suggesting that the cells’ energy-producing machinery isn’t working properly. This impaired energy production could lead to cell death and tissue damage, resulting in the neurological problems seen in many people with the condition, including intellectual disability, developmental delays, and in some cases, permanent neurological damage from stroke-like episodes.[3][4]
During times of metabolic stress—such as when a person is sick with an infection, hasn’t eaten for a while, or is under physical stress from surgery or injury—the body breaks down its own proteins and fats for energy. In people with MMA, this breakdown releases large amounts of the problem amino acids and fatty acids that cannot be processed, leading to a rapid buildup of toxic substances. This explains why people with MMA can suddenly become severely ill during what would be minor illnesses for most people. The condition also often causes the production of substances called ketone bodies, resulting in ketonuria (ketones in the urine).[6][10]
The toxic buildup also affects blood sugar regulation, often causing hypoglycemia (low blood sugar), which can contribute to lethargy and other symptoms. High levels of ammonia in the blood, known as hyperammonemia, develop because the backed-up metabolic pathway interferes with other processes, including the body’s ability to clear ammonia. Elevated ammonia is particularly dangerous to the brain and can cause confusion, altered consciousness, and brain swelling. Additionally, high levels of the amino acid glycine may be present, a condition called hyperglycinemia.[6][10]
The liver, where most of this metabolic processing occurs, can become damaged over time. Fatty liver develops as the mobilized fatty acids that cannot be properly broken down accumulate in liver cells. This is why some sources describe MMA as a liver disorder, though the consequences affect the entire body. The kidneys also suffer progressive damage from the chronic exposure to methylmalonic acid and other toxic metabolites, leading to chronic kidney disease that worsens over time. Some people with MMA eventually develop end-stage kidney failure requiring dialysis or transplantation.[2][12]
Interestingly, research involving liver transplantation in people with MMA has revealed that the neurological problems may not be solely due to metabolic abnormalities originating in the liver. Even after liver transplantation, which corrects the metabolic derangement in the liver, some patients continue to experience neurological worsening and stroke-like episodes. This suggests that local metabolic disturbances in the brain itself contribute to the neurological complications, independent of what’s happening in the liver. This finding has important implications for understanding the disease and developing treatments.[3][13]